Sale based on enterprise value of $8.4 billion (EUR 7.15B), reflecting a post-MOU $350M (€300M) price reduction, offset by positive foreign currency impact Net proceeds to Bombardier expected to be ~$4.0B at closing Closing now expected in the first quarter of 2021, subject to customary closing conditions and remaining regulatory …
Read More »RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
Opaganib blocks SARS-Cov-2 virus replication Opaganib blocks SARS-Cov-2 virus replication Opaganib completely inhibited SARS-CoV-2 viral replication as measured after three days incubation in an in vitro model of human bronchial tissue, comparing favorably with remdesivir, the positive control in the study — Opaganib is uniquely positioned as an orally-administered potential …
Read More »INVNT GROUP]™ Appoints Managing Director In EMEA To Fuel Further Growth Of New Portfolio
LONDON, UK, Sept. 02, 2020 (GLOBE NEWSWIRE) — [INVNT GROUP], THE GLOBAL BRANDSTORY PROJECT™ has recruited a new Managing Director for EMEA in renowned and highly regarded industry leader, Claudia Stephenson, a move that has been fuelled by increased demand for the GROUP’s multi-disciplinary offering amid the pandemic. An excellent …
Read More »Bombardier Announces Closing of Senior Secured Credit Facility
MONTREAL, Aug. 19, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) announced today that it has successfully closed the previously announced three-year $1.0 billion senior secured term loan facility (the “Facility”) with HPS Investment Partners, LLC, acting as administrative agent, collateral agent and the lead lender for a group that included …
Read More »